Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020109646 - PHASCOLARCTOBACTERIUM FAECIUM FOR USE IN THE PREVENTION AND TREATMENT OF OBESITY AND ITS COMORBIDITIES

Publication Number WO/2020/109646
Publication Date 04.06.2020
International Application No. PCT/ES2019/070821
International Filing Date 02.12.2019
IPC
C12N 1/20 2006.01
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
1Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
20Bacteria; Culture media therefor
A61K 35/741 2015.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
74Bacteria
741Probiotics
A23L 33/135 2016.01
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D91; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
33Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
10using additives
135Bacteria or derivatives thereof, e.g. probiotics
CPC
A23L 33/135
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT
33Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
10using additives
135Bacteria or derivatives thereof, e.g. probiotics
A61K 35/741
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
74Bacteria
741Probiotics
C12N 1/20
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
1Microorganisms, e.g. protozoa; Compositions thereof
20Bacteria
Applicants
  • CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) [ES]/[ES]
Inventors
  • SANZ HERRANZ, Yolanda
  • LÓPEZ ALMELA, Inmaculada
  • GÓMEZ DEL PULGAR VILLANUEVA, Eva Mª
  • BENITEZ-PÁEZ, Alfonso
  • ROMANI PÉREZ, Marina
Agents
  • PONS ARIÑO, Angel
Priority Data
P20183116630.11.2018ES
Publication Language Spanish (ES)
Filing Language Spanish (ES)
Designated States
Title
(EN) PHASCOLARCTOBACTERIUM FAECIUM FOR USE IN THE PREVENTION AND TREATMENT OF OBESITY AND ITS COMORBIDITIES
(ES) PHASCOLARCTOBACTERIUM FAECIUM PARA SU USO EN LA PREVENCIÓN Y TRATAMIENTO DE LA OBESIDAD Y SUS COMORBILIDADES
(FR) PHASCOLARCTOBACTERIUM FAECIUM DESTINÉ À ÊTRE UTILISÉ DANS LA PRÉVENTION ET LE TRAITEMENT DE L'OBÉSITÉ ET DE SES COMORBIDITÉS
Abstract
(EN)
The present invention relates to the strain Phascolarctobacterium faecium DSM 32890 and to its use for the regulation of appetite and the treatment and/or prevention of overweight or the associated metabolic and immunological changes, specifically, hyperglycaemia, glucose intolerance, insulin resistance, dyslipidemia (hypertriglyceridemia, hypercholesterolemia), metabolic syndrome, diabetes and intestinal and/or peripheral tissue inflammation.
(ES)
La presente invención se refiere a la cepa P. faecium DSM 32890 y a su uso para regular el apetito y el tratamiento y/o la prevención del sobrepeso u las alteraciones metabólicas e inmunológicas asociadas: en concreto la hiperglucemia, la intolerancia a la glucosa, la resistencia insulínica, la dislipemía (hipertrigliceridemía, hipercolesterolemia), el síndrome metabólico, la diabetes y la inflamación intestinal y/o de tejidos periféricos.
(FR)
La présente invention se rapporte à la souche P. faecium DSM 32890 et à son utilisation pour réguler l'appétit et le traitement et/ou la prévention du surpoids ou les altérations métaboliques et immunologiques associées: concrètement l'hyperlycémie, l'intolérance au glucose, la résistance insulinique, la dyslipidémie (hypertriglycéridémie, hypercholestérolémie), le syndrome métabolique, le diabète et l'inflammation intestinale et/ou des tissus périphériques.
Also published as
Latest bibliographic data on file with the International Bureau